May 28 | 2026
THIS PRESS RELEASE IS AN ENGLISH TRANSLATION OF THE LEGALLY BINDING SWEDISH PRESS RELEASE: “PUBLICERING AV ÅRSREDOVISNINGEN FÖR 2CUREX AB (publ)”.
Read more
May 28 | 2026
Publicering av årsredovisningen för 2cureX AB (publ)
Read more
May 25 | 2026
Rättelse: Kallelse till årsstämma i 2cureX AB
Read more
May 25 | 2026
Correction: Notice of annual general meeting in 2cureX AB
Read more
May 25 | 2026
Notice of annual general meeting in 2cureX AB
Read more
May 25 | 2026
Kallelse till årsstämma i 2cureX AB
Read more
May 20 | 2026
2cureX AB Expands Functional Precision Medicine Infrastructure Through Strategic Collaboration with StoreMyTumor
Read more
May 19 | 2026
2cureX AB’s Executive Management is pleased to invite shareholders and investors to a live webcast and business update on 20 May at 7pm CET.
Read more
April 22 | 2026
2cureX AB completes oversubscribed directed issue
Read more
February 26 | 2026
2cureX AB (publ) publishes Interim Report for the Second Half of 2025
Read more
August 29 | 2025
CEO Nathaniel Hutley presents a strategic update on 2cureX’s new Website Blog.
Read more
August 21 | 2025
2cureX AB (“2cureX”) hereby publishes the interim report for the first half year of 2025.
Read more
July 11 | 2025
Improved communication from 2cureX AB
Read more
July 2 | 2025
Correction: CEO Nathaniel Hutley presents latest news from 2cureX on July 2nd 2025.
Read more
July 1 | 2025
2cureX AB is in the process of securing a strategic collaboration with PreComb Therapeutics AG.
Read more
June 27 | 2025
KOMMUNIKÉ FRÅN ÅRSSTÄMMAN I 2CUREX AB (PUBL)
Read more
June 13 | 2025
CEO Nathaniel Hutley presents latest news from 2cureX on July 2nd 2025.
Read more
May 30 | 2025
NOTICE OF ANNUAL GENERAL MEETING OF 2CUREX AB (publ).
Read more